Screener
Insmed INSM Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Insmed’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104506-26-000041
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenues, net | $425,486 | $107,415 | $731,450 | $200,238 |
| Operating expenses: | ||||
| Cost of product revenues (excluding amortization of intangible assets) | 67,212 | 28,075 | 114,632 | 49,353 |
| Research and development | 210,034 | 177,190 | 419,519 | 329,767 |
| Selling, general and administrative | 247,467 | 154,763 | 494,726 | 302,308 |
| Amortization of intangible assets | 2,081 | 1,263 | 4,162 | 2,526 |
| Change in fair value of contingent consideration | (99,760) | 59,000 | (146,721) | 77,300 |
| Total operating expenses | 427,034 | 420,291 | 886,318 | 761,254 |
Item 1C. Consolidated Financial Statements
FAQ
- What is Insmed's total revenue?
- Insmed (INSM) reported total revenue of $425.49M in Q2 2026.
- How has Insmed's total revenue changed year-over-year?
- Insmed's total revenue increased by 296.1% year-over-year, from $107.42M to $425.49M.
- What is the long-term trend for Insmed's total revenue?
- Over 4 years (2021 to 2025), Insmed's total revenue has grown at a 33.9% compound annual growth rate (CAGR), from $188.46M to $606.42M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Insmed's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude